Tirzepatide

$ 500.00$ 750.00

Tirzepatide is a dual GIP and GLP-1 receptor agonist that improves blood sugar control, enhances satiety, and supports significant weight loss.

Category

Substance

Retatrutide

Dosage

100mg 10x10mg, 200mg 10x20mg, 300mg 10x30mg

Manufacturer

AP Labs

Warehouse

Bulk Peptides

  Hurry up! Sale end in:
  •  Delivery & Return

    Delivery


    Turkish Pharmacy - $50 shipping cost.
    Minimum order $200.

    Indian Pharmacy - $35 shipping cost.
    Minimum order - $150.

    US Domestic - All 3 US locations have $15 shipping cost EACH.
    US Pharma - $150 minimum order.
    US Peptides/HGH - $150 minimum order.
    Oils & Tablets - $200 minimum order.

    For extensive information about delivery read more here...
  ... people are viewing this right now

  Share
! READ BEFORE ORDERING !

Tirzepatide is a novel synthetic peptide that acts as a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism provides potent effects on glucose regulation, appetite suppression, and weight reduction, making it a groundbreaking therapy in type 2 diabetes and obesity management.

Mechanisms and effects:

  • Blood sugar regulation: Enhances insulin secretion and reduces glucagon release in a glucose-dependent manner, improving glycemic control.
  • Appetite suppression: Slows gastric emptying and increases satiety, leading to reduced calorie intake.
  • Weight management: Clinical trials demonstrate greater weight loss compared to GLP-1 agonists alone (like semaglutide).
  • Metabolic improvements: Supports reductions in visceral fat, blood pressure, and lipid levels, contributing to improved cardiometabolic health.
  • Once-weekly dosing: Long half-life allows for convenient weekly subcutaneous injections.

Tirzepatide is FDA-approved under the brand names Mounjaro® (for type 2 diabetes) and Zepbound® (for obesity/weight management). Common side effects are primarily gastrointestinal (nausea, diarrhea, or vomiting), similar to other incretin-based therapies, and often decrease with continued use.

In summary, Tirzepatide is a first-in-class dual GIP/GLP-1 receptor agonist peptide that delivers powerful improvements in glucose control, appetite regulation, and weight reduction, making it one of the most effective modern treatments for type 2 diabetes and obesity.

My Cart
Wishlist
Recently Viewed
Categories

Wait! before you leave...

Join our community for the latest news and updates


    Subscribe for our Wholesale Deals